Sodium-glucose co-transporter 2 inhibitors in COVID-19: meeting at the crossroads between heart, diabetes and infectious diseases
Theocharis Koufakis, Antonis N. Pavlidis, Symeon Metallidis, Kalliopi Kotsa
Topics & Concepts
MedicineDiabetes mellitusProinflammatory cytokineCoronavirus disease 2019 (COVID-19)Diabetic ketoacidosisOxidative stressInflammationPharmacologyIntensive care medicineDiseaseInternal medicineInfectious disease (medical specialty)EndocrinologyDiabetes Treatment and ManagementDiabetes and associated disordersPancreatic function and diabetes